Presentation List Back to menu 20/05/2008 Room Auditorio 09.30 - 10.00 Pieter van Keep Memorial Lecture Pines A. The voice of science 10.00 - 10.30 Main Lecture Mikkola T. Is there a critical therapeutic window for starting HRT? 11.00 - 12.30 Updates on observtional and clinical trials Grodstein F. Postmenopausal hormone therapy and stroke Naftolin F. The Kronos early estrogen prevention study (KEEPS) Miller V.M. Baseline characterictics of women enrolled in KEEPS Wolff E.F. Atherosclerosis and menopausal symptoms Harman S.M. Relationship of coronary calcification to conventional and metabolic risk factors 14.30 - 16.00 Primary cardiovascular prevention in perimenopausal women Laurent S. Are women excluded from 2007 ESH/ESC guidelines for the management of hypertension Palacios S. Is cardiovascular risk in postmenopausal women poorly assessed? Rees M. Translation of guidelines into clinical practice 21/05/2008 Room Auditorio 09.30 - 10.00 Plenary Lecture Speroff L. Postmenopausal hormone therapy and the risk of breast cancer - a contrary thought 11.00 - 12.30 Menopause and the metabolic syndrome Gupta P. Adiposity and cardiovascular health in postmenopausal women Gaspard U. Menopause and insulin resistance Lowe G. Different effects of oral versus non-oral hormone replacement therapy on clotting Stevenson J. Metabolic effects of new hormonal agents 14.30 - 16.00 HRT and gynecological cancer Kenemans P. Tibolone in breast cancer patients: first results of the LIBERATE trial Ulrich L. HRT and endometrial cancer 18.00 - 18.30 Plenary Lecture: Presentation by the winner of the Henry Burger Award Manson J. E. Hormone therapy and cardiovascular disease: is timing everything? 22/05/2008 Room Auditorio 09.30 - 10.00 HRT and the metabolic syndrome Keller U. HRT and the metabolic syndrome 10.00 - 10.30 Main Lecture Christiansen C. Natural hormones with chondroprotective effect 11.00 - 12.30 Osteoporosis management Rizzoli R. Treatment of postmenopausal osteoporosis: who, when and why Reginster J.-Y. New trends in the management of osteoporosis 14.30 - 16.00 Alternatives to HRT for climacteric symptoms Panay N. SSRIs/SNRIs for vasomotor symptoms Geller S. Safety and Efficacy of Isoflavones from Soy and Red Clover Stojanovska L. The Effects of food with Isoflavones in Cardiovascular and Osteoporosis prevention Wuttke W. Why should phytoestrogens be/or not be recommended? 23/05/2008 Room Auditorio 09.30 - 10.45 IMS challenges for the future Sturdee D. The future role of IMS Pines A. The role of the WSSM Birkhaeuser M. The future of IMS in different cultures 11.15 - 12.45 Menopause and aging, quality of life and sexuality Genazzani A.R. Female sexuality and menopause: conclusion of the 6th IMS workshop Nappi R. Aging & sexuality in women Studd J. Estrogen therapy for depression in perimenopausal women Dennerstein L. Sex and sexagenarians Back to menu